Literature DB >> 22541758

Does cardiology intervention improve mortality for post-operative troponin elevations after emergency orthopaedic-geriatric surgery? A randomised controlled study.

Carol P Chong1, William J van Gaal, Julie E Ryan, Konstantinos Profitis, Judy Savige, Wen Kwang Lim.   

Abstract

OBJECTIVES: Troponin elevations are common after emergency orthopaedic surgery and confer a higher mortality at one year. The objective was to determine if comprehensive cardiology care after emergency orthopaedic surgery reduces mortality at one year in patients who sustain a post-operative troponin elevation versus standard care.
METHODS: A randomised controlled trial was conducted at a metropolitan teaching hospital in Melbourne, Australia. 187 consecutive patients were eligible with 70 patients randomised. Troponin I was tested peri-operatively and patients with a troponin elevation were randomised to cardiology care versus standard ward management. The main outcome measure was one year mortality.
RESULTS: The incidence of a post-operative troponin elevation was 37.4% (70/187) and these 70 patients were randomised. In-hospital cardiac complications were similar between the randomised groups: standard care (7/35 or 20.0%) versus cardiology care (8/35 or 22.9%). There was no difference in 1 year mortality between the randomised groups (6/35 or 17.1% in each group). Multivariate predictors of 1 year mortality were post-operative troponin elevation OR 4.3 (95% CI, 1.1-16.4, p=0.035), age OR 1.1 (95% CI, 1.02-1.2, p=0.016) and number of comorbidities OR 2.1 (95% CI, 1.3-3.5, p=0.004). At 1 year 35/187 (18.7%) sustained a cardiac complication and 23/35 (65.7%) had a troponin elevation.
CONCLUSIONS: There was no difference in mortality between patients with a post-operative troponin elevation randomised to cardiology care compared with standard care. Troponin elevation predicted one year mortality. Further research is needed to find an effective intervention to reduce mortality. Crown
Copyright © 2012. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22541758     DOI: 10.1016/j.injury.2012.03.034

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  4 in total

Review 1.  Sleep apnea in total joint arthroplasty patients and the role for cardiac biomarkers for risk stratification: an exploration of feasibility.

Authors:  M Melanie Lyons; Nitin Y Bhatt; Elizabeth Kneeland-Szanto; Brendan T Keenan; Joanne Pechar; Branden Stearns; Nabil M Elkassabany; Stavros G Memtsoudis; Allan I Pack; Indira Gurubhagavatula
Journal:  Biomark Med       Date:  2016       Impact factor: 2.851

2.  Relation of perioperative elevation of troponin to long-term mortality after orthopedic surgery.

Authors:  Brandon S Oberweis; Nathaniel R Smilowitz; Swetha Nukala; Andrew Rosenberg; Jinfeng Xu; Steven Stuchin; Richard Iorio; Thomas Errico; Martha J Radford; Jeffrey S Berger
Journal:  Am J Cardiol       Date:  2015-03-23       Impact factor: 2.778

3.  Use of ivabradine and atorvastatin in emergent orthopedic lower limb surgery and computed tomography coronary plaque imaging and novel biomarkers of cardiovascular stress and lipid metabolism for the study and prevention of perioperative myocardial infarction: study protocol for a randomized controlled trial.

Authors:  Nima Rudd; Ivan Subiakto; Muhammad Asrar Ul Haq; Vivek Mutha; William J Van Gaal
Journal:  Trials       Date:  2014-09-07       Impact factor: 2.279

4.  Causes and prevention of postoperative myocardial injury.

Authors:  Laura Verbree-Willemsen; Remco B Grobben; Judith Ar van Waes; Linda M Peelen; Hendrik M Nathoe; Wilton A van Klei; Diederick E Grobbee
Journal:  Eur J Prev Cardiol       Date:  2018-09-12       Impact factor: 7.804

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.